Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Pucotenlimab by Lepu Biopharma for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer): Likelihood of Approval
Pucotenlimab is under clinical development by Lepu Biopharma and currently in Phase II for Non Muscle Invasive Bladder Cancer (NMIBC)...
Pucotenlimab by Lepu Biopharma for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
Pucotenlimab is under clinical development by Lepu Biopharma and currently in Phase II for Head And Neck Squamous Cell Carcinoma...
Pucotenlimab by Lepu Biopharma for Nasopharyngeal Cancer: Likelihood of Approval
Pucotenlimab is under clinical development by Lepu Biopharma and currently in Phase II for Nasopharyngeal Cancer. According to GlobalData, Phase...